23.60
price down icon5.98%   -1.50
after-market Dopo l'orario di chiusura: 23.52 -0.08 -0.34%
loading

Immunovant Inc Azioni (IMVT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
13.21%
114.36
131.76 127.22 115.74 94.28
Income/Loss From Continuing Operations Before Tax
13.36%
-109.08
-125.91 -119.70 -109.04 -87.07
Income Tax Expense/Benefit
161.28%
1.552
0.594 0.913 0.078 0.077
Income/Loss From Continuing Operations After Tax
12.54%
-110.64
-126.50 -120.61 -109.12 -87.15
Net Income/Loss
12.54%
-110.64
-126.50 -120.61 -109.12 -87.15
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4.53%
181.51
173.64 170.87 146.47 146.09
Diluted Average Shares
4.53%
181.51
173.64 170.87 146.47 146.09
Basic Earnings Per Share
16.44%
-0.61
-0.73 -0.71 -0.74 -0.60
Diluted Earnings Per Share
16.44%
-0.61
-0.73 -0.71 -0.74 -0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.79
price down icon 0.69%
$27.80
price down icon 1.77%
$52.40
price down icon 2.84%
$90.00
price down icon 5.12%
$142.70
price down icon 0.85%
biotechnology ONC
$282.29
price down icon 1.75%
Capitalizzazione:     |  Volume (24 ore):